New Medical School to Be Established in Northwest Arkansas as Part of Alice Walton s Vision for Whole Health
Leadership Team Announced for Whole Health School of Medicine and Health Sciences
News provided by
Share this article
founded by Alice Walton, today announced plans for a Whole Health School of Medicine and Health Sciences (School of Medicine) in Northwest Arkansas. The Whole Health School of Medicine will help medical students rise to the health challenges of the 21
st century through a reimagination of American medical education that incorporates mental, emotional, physical and spiritual health, the elements of Whole Health, to help people live healthier and happier lives, said Alice Walton.
Share this article
FRANKLIN LAKES, N.J., March 4, 2021 /PRNewswire/
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, Inc. ( GSL ), a privately-held company that develops smart medication devices for the storage and tracking of controlled substances and patient specific medications that improve the security, efficiency and compliance of medication storage, as well as analytic capabilities to further improve inventory management, including of controlled substances, regulatory compliance and patient safety.
This acquisition expands BD s advanced medication management capabilities to further meet the needs of retail pharmacies, including those in outpatient settings.
/PRNewswire/ Senseon®, maker of cabinet-level access control systems, has released its new 2Way-EL Electronic Lock for two-way-travel compartments. The.
BioIntelliSense Partners with Leukemia & Lymphoma Society to Incorporate the BioSticker™ Medical Device for Continuous Monitoring in Clinical Trials
LLS clinical trials will use the FDA-cleared BioSticker to evaluate correlation of vital signs and select symptoms to treatment
News provided by
Share this article
DENVER, March 4, 2021 /PRNewswire/
BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the company has entered into a strategic partnership with The Leukemia & Lymphoma Society (LLS) to incorporate use of the BioSticker™ medical wearable device and data services in clinical trials of hematological cancer patients.
The BioSticker is the first FDA-cleared single-use medical device that enables 30 days of continuous vital signs monitoring. The BioIntelliSense medical grade Data-as-a-Service (DaaS) platform and FDA 510(k) Class II medical wearable device provides a new standard for Remote Patient Monitoring (RP
Olympus Launches Awareness Initiatives in Support of Colorectal Cancer Awareness Month
Olympus commits to the prevention and detection of colon cancer through charitable support and awareness events
News provided by
Share this article
Share this article
CENTER VALLEY, Pa., March 4, 2021 /PRNewswire/ Olympus announced today its 2021 support of major national colorectal cancer (CRC) organizations and initiatives to increase screening and awareness, as part of National Colorectal Cancer Awareness Month, which is observed annually to educate the public on the importance of colorectal cancer prevention. These initiatives are more important than ever, with a ~90% decline of colorectal cancer screening rates since the start of pandemic. This decline puts thousands at risk for delayed or missed diagnoses.